Originally developed for diabetes, then approved for obesity, and now showing promise for various psychiatric conditions including binge eating disorder, substance use disorders, and possibly depression itself
Initially launched in 2023 for obesity-related conditions, its potent weight loss effects (20-25% body weight reduction) make it a promising solution, given that excess weight is a leading risk factor for OSA in 75-80% of cases
If side effects are causing anxiety or affecting your day-to-day life, a Slim Shot consult or follow-up visit is an opportunity to pause, reassess, and make sure your treatment plan continues to fit your needs
Prescription GLP-1 drugs keep receptor activity high all day and can drive double-digit weight-loss percentages
Lesser, M.P
Discuss duration and dosing with your provider